Intervention

Folic acid

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 19 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials19

Recruiting1

Common conditions19

Lead sponsors shown15

Clinical trials

19 shown

Neurovascular Transduction During Exercise in Chronic Kidney DiseaseNCT02947750 · 2016-10-01

Efficacy of Melatonin in the Treatment of Diabetic Nephropathy Compared With Folic AcidNCT07825961 · 2025-04-01

Folic Acid Interferes With Radiation EsophagitisNCT05296369 · 2022-03-01

Effects of Oral Inositol Supplementation on Obstetrics Outcomes in PCOS WomenNCT03585738 · 2022-01-01

NOT_YET_RECRUITING

Hydroxychloroquine in Prevention of PreeclampsiaNCT04755322 · 2021-03-01

Effect of Folic Acid and Vitamin B12 Supplementation in Subjects With Type 2 DiabetesNCT02786823 · 2017-05-01

Evaluation of Pharmacokinetics and Safety of GSK3196165 in Combination With Methotrexate in Japanese Subjects With Rheumatoid ArthritisNCT03028467 · 2017-01-24

Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid ArthritisNCT02762838 · 2016-01-01

Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid ArthritisNCT02504671 · 2015-07-23

A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)NCT02293902 · 2014-11-01

Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)NCT01953536 · 2014-04-01

Inositol Stereoisomers to Treat Gestational DiabetesNCT02097069 · 2014-04-01

Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV MedicationsNCT01949116 · 2014-01-31

Folic Acid Supplementation in Women of Child Bearing AgeNCT01841658 · 2013-04-01

Blood Pressure Lowering Effect of B-vitamins in Adults With a Genetic Pre-disposition to Elevated Blood Pressure.NCT04278378 · 2011-06-28

A Study for Patients With Non-Squamous Non-Small Cell Lung CancerNCT00609518 · 2008-02-01

Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA)NCT01308255 · 2006-09-01

The Effect of Folic Acid Administration in the Progression of MicroalbuminuriaNCT00737126 · 2004-01-01

Antifolate Effectiveness in ArthritisNCT00000395 · 1996-09-01

Common conditions

Rheumatoid Arthritis4 Arthritis, Rheumatoid2 Adjuvant Arthritis1 Blood Pressure1 Breast Neoplasms1 Diabetes Mellitus, Type 21 Diabetic Nephropathies1 Diabetic Nephropathy1 Folic Acid1 Gestational Diabetes Mellitus1 HIV Infections1 Hyperhomocysteinemia1 Lung Cancer1 Melatonin1 Non Small Cell Lung Cancer1 Obesity1 Polycystic Ovary Syndrome1 Preeclampsia1 Renal Insufficiency, Chronic1

Leading sponsors

GlaxoSmithKline 2 All India Institute of Medical Sciences, Bhubaneswar 1 Assiut University 1 Biocad 1 Eli Lilly and Company 1 Emory University 1 Endocyte 1 Guizhou Medical University 1 Hospital Universitario Dr. Jose E. Gonzalez 1 National Institute of Allergy and Infectious Diseases (NIAID) 1 Sanofi 1 Tanta University 1 Università degli Studi 'G. d'Annunzio' Chieti e Pescara 1 Università degli Studi dell'Insubria 1 University of Alabama at Birmingham 1

Trial status mix

COMPLETED14

UNKNOWN2

NOT_YET_RECRUITING1

RECRUITING1

WITHDRAWN1

Phase mix

NA8

PHASE28

PHASE33

PHASE11

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.